Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization

Clinical Microbiology and Infection

Volumn 17, Issue 11, 2011, Pages 1659-1665

  Garcia Vidal, C ^a   Viasus, D ^a   Roset, A ^a   Adamuz, J ^a   Verdaguer, R ^a   Dorca, J ^a   Gudiol, F ^a   Carratala J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Aspiration pneumonia; Healthcare associated pneumonia; Methicillin resistant Staphylococcus aureus; Multidrug resistant pathogens; Nursing home pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEALTH CARE ACQUIRED PNEUMONIA; HEALTH PROGRAM; HEMODIALYSIS; HOSPITALIZATION; HUMAN; LEGIONELLA PNEUMOPHILA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; MULTIPLE ORGAN FAILURE; NURSING HOME; PENICILLIN RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA;

ENTEROBACTERIACEAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA;

EID: 80053526515     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03484.x     Document Type: Article

References (22)

1. Niederman MS, Craven DE, Bonten MJ et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
2. Carratalà J, Mykietiuk A, Fernández-Sabé N et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
3. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US data-base of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
4. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
5. Shindo Y, Sato S, Maruyama E et al. Health-care associated pneumonia among hospitalizad patients in a Japanese community hospital. Chest 2009; 135: 633-640.
6. Sopena N, Sabrià M; Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127: 213-219.
7. Abrahamian FM, Deblieux PM, Emerman CL et al. Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med 2008; 26: 1-8.
8. Valles J, Calbo E, Anoro E et al. Bloodstream infections in adults: importance of healthcare-associated infections. J Infect 2008; 56: 27-34.
9. Ewig S, Welte T, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10: 279-287.
10. Brito V, Niederman M. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009; 22: 316-325.
11. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: eleventh informational supplement. NCCLS document no. M100-S11. Wayne, PA: NCCLS, 2001.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically: approved standard, 5th edn. Document M7-A5. Wayne, PA: NCCLS, 2000; supplemental tables M100-S10.
14. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
15. Carratalà J, Fernández-Sabé N, Ortega L et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005; 142: 165-172.
16. Fernández-Sabé N, Carratalà J, Rosón B et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics and outcomes. Medicine (Baltimore) 2003; 82: 159-169.
17. Garcia-Vidal C, Carratalà J. Current clinical management of Legionnaires' disease. Expert Rev Anti Infect Ther 2006; 4: 995-1004.
18. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008; 168: 2205-2210.
19. Polverino E, Dambrava P, Cillóniz C et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65: 354-359.
20. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665-671.
21. Garcia-Vidal C, Carratalà J, Díaz V et al. Factors associated with prolonged hospital stay in community-acquired pneumonia. Enferm Infecc Microbiol Clin 2009; 27: 160-164.
22. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.